Zobrazeno 1 - 10
of 2 642
pro vyhledávání: '"RC254-282"'
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3212-3226 (2024)
Neuroblastoma is a pediatric cancer with significant clinical heterogeneity. Despite extensive efforts, it is still difficult to cure children with high-risk neuroblastoma. Immunotherapy is a promising approach to treat children with this devastating
Externí odkaz:
https://doaj.org/article/b3c834f14f6c4248a411664e8223920c
Autor:
Gyu Sang Yoo, Sunmin Park, Chai Hong Rim, Won Kyung Cho, Ah Ram Chang, Young Seok Kim, Yong Chan Ahn, Eui Kyu Chie
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3239-3251 (2024)
Background: Interest in the oligometastatic prostate cancer (OMPC) is increasing, and various clinical studies have reported the benefits of metastasis-directed radiation therapy (MDRT) in OMPC. However, the recognition regarding the adopted definiti
Externí odkaz:
https://doaj.org/article/b0e0ff83c6a348c08c50fc4380a7237f
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3301-3310 (2024)
This epidemiological model forecasted reductions in recurrences and recurrence treatment cost savings with adjuvant atezolizumab vs best supportive care among Canadians with stage II-IIIA non-small cell lung cancer (NSCLC) at national and provincial
Externí odkaz:
https://doaj.org/article/d30db341b4004e05979c5ce70fad377f
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3311-3328 (2024)
Differentiated high-grade thyroid carcinoma (DHGTC) is a new subset within the spectrum of thyroid malignancies. This review aims to provide a comprehensive overview of DHGTC, focusing on its historical perspective, diagnosis, clinical characteristic
Externí odkaz:
https://doaj.org/article/5fd7908f074b404d8a74ec63b90f41fc
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3269-3277 (2024)
Introduction: Although virtual care (VC) has become an integral part of oncology care and healthcare delivery, clinicians’ perspectives on and satisfaction with this modality are not well understood. Methods: Using a National Network Forum framewor
Externí odkaz:
https://doaj.org/article/f1d343f55cc04104ae29ac03eb700789
Autor:
Lorraine Elit, Florence Manjuh, Lillian Kila, Beatrice Suika, Manuela Sinou, Eliane Bozy, Ethel Vernyuy, Amandine Fokou, Edith Welty, Thomas Welty
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3227-3238 (2024)
Introduction: The rates of cervical cancer screening in Cameroon are unknown and HPV vaccination coverage for age-appropriate youths is reported at 5%. Objectives: To implement the mother–child approach to cervical cancer prevention (cervical scree
Externí odkaz:
https://doaj.org/article/3afcdc62ba014f5694c7fd28759c06c1
Autor:
Dan Cristian Moraru, Mihaela Pertea, Stefana Luca, Valentin Bejan, Andrian Panuta, Raluca Tatar, Dan Mircea Enescu, Dragos Viorel Scripcariu, Viorel Scripcariu
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3253-3268 (2024)
Background: Abdominoperineal resection (APR)—the standard surgical procedure for low-lying rectal cancer (LRC)—leads to significant perineal defects, posing considerable reconstruction challenges that, in selected cases, necessitate the use of pl
Externí odkaz:
https://doaj.org/article/549c6f1e97e74df1bfebf50772383303
Autor:
Brittany Mutsaers, Tori Langmuir, Carrie MacDonald-Liska, Justin Presseau, Gail Larocque, Cheryl Harris, Marie-Hélène Chomienne, Lauriane Giguère, Paola Michelle Garcia Mairena, Dina Babiker, Kednapa Thavorn, Sophie Lebel
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3278-3290 (2024)
Primary care providers (PCPs) have been given the responsibility of managing the follow-up care of low-risk cancer survivors after they are discharged from the oncology center. Survivorship Care Plans (SCPs) were developed to facilitate this transiti
Externí odkaz:
https://doaj.org/article/fb424822e00444b78d6e2775b030a100
Autor:
Małgorzata Domagała-Haduch, Anita Gorzelak-Magiera, Łukasz Michalecki, Iwona Gisterek-Grocholska
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3291-3300 (2024)
Despite the advancements made in oncology in recent years, the treatment of pancreatic cancer remains a challenge. Five-year survival rates for this cancer do not exceed 10%. Among the reasons contributing to poor treatment outcomes are the oligosymp
Externí odkaz:
https://doaj.org/article/e1e3c6971220414f8badefc6ad22d464
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3495-3512 (2024)
Cancer immunotherapy in the form of immune checkpoint inhibitors has led to a dramatic increase in the survival of patients with lung cancer across all stages. Over the past decade, the field has experienced rapid maturation; however, several challen
Externí odkaz:
https://doaj.org/article/8fe93588e38549c7b6f8e2f284d94205